Table 4 Factors contributing to poor glycemic control status of diabetic patients with comorbid CKD attending adult DM clinic of TASH, from March 15 to May 15, 2024 (n = 384)
Variables | Glycemic Control | COR (95% CI) | P-value | AOR (95% CI) | P-value | |
|---|---|---|---|---|---|---|
Good, n(%) | Poor, n(%) | |||||
Cardiovascular Disorders | Â | |||||
No | 6 (35.3) | 197 (53.7) | 1 | 1 | 1 | 1 |
Yes | 11 (64.7) | 170 (46.3) | 0.47 (0.17–1.30) | 0.146 | 0.75 (0.21–2.66) | 0.651 |
Hypertension | Â | |||||
No | 7 (41.2) | 104 (28.3) | 1 | 1 | 1 | 1 |
Yes | 10 (58.8) | 263 (71.7) | 1.77 (0.66–4.78) | 0.250 | 3.70 (1.08–12.71) | 0.038 |
Aspirin Use | Â | |||||
No | 12 (70.6) | 306 (83.4) | 1 | 1 | 1 | 1 |
Yes | 5 (29.4) | 61 (16.6) | 0.48 (0.16–1.41) | 0.180 | 0.57 (0.18–1.87) | 0.355 |
Number of Comorbidity | Â | |||||
≤ 2 | 10 (58.8) | 291 (79.3) | 1 | 1 | 1 | 1 |
> 2 | 7 (41.2) | 76 (20.7) | 0.37 (0.14–1.01) | 0.053 | 0.36 (0.09–1.52) | 0.164 |
Regimen Change in Past 1 Year | Â | |||||
No | 5 (29.4) | 204 (55.6) | 1 | 1 | 1 | 1 |
Yes | 12 (70.6) | 163 (44.4) | 0.33 (0.12–0.96) | 0.043 | 0.34 (0.11–1.01) | 0.050 |